Compile Data Set for Download or QSAR
Report error Found 77 of ec50 for UniProtKB: O96013
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101479(US8530652, 6 | US8530652, 50 | US8524710, 56)
Affinity DataKi:  2.80nM EC50:  0.940nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389123(CHEMBL2064631)
Affinity DataEC50:  1nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101546(US8530652, 73 | US8530652, 125 | US8530494, 211)
Affinity DataKi:  1.60nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101543(US8530652, 122 | US8530652, 70 | US8530494, 206)
Affinity DataKi:  8.80nM EC50:  1.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101542(US8530652, 69 | US8530652, 121 | US8530494, 207)
Affinity DataKi:  1.90nM EC50:  3nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101532(US8530652, 59 | US8530652, 110 | US8530494, 201)
Affinity DataKi:  170nM EC50:  2.40nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101530(US8530652, 57 | US8530494, 29 | US8530494, 7)
Affinity DataKi:  14nM EC50:  2.5nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101537(US8530652, 115 | US8530652, 64 | US8530494, 204)
Affinity DataKi:  3nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM4838(US8524710, 83 | US8530494, 13 | US8530652, 52)
Affinity DataKi:  3.5nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM4838(US8524710, 83 | US8530494, 13 | US8530652, 52)
Affinity DataKi:  3.5nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101547(US8530652, 74 | US8530652, 126 | US8530494, 212)
Affinity DataKi:  3.60nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101533(US8530652, 111 | US8530652, 60 | US8530494, 103)
Affinity DataKi:  40nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101549(US8530652, 128 | US8530652, 76 | US8530494, 109)
Affinity DataKi:  8.30nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101548(US8530652, 75 | US8530652, 127 | US8530494, 108)
Affinity DataKi:  5.20nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101536(US8530652, 63 | CHEMBL3128043 | US8530494, 203)
Affinity DataKi:  20nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101552(US8530652, 79 | US8530652, 131 | US8530494, 214)
Affinity DataKi:  39nM EC50: >3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101539(US8530652, 66 | US8530652, 117 | US8530494, 106)
Affinity DataKi:  170nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389121(CHEMBL2064628)
Affinity DataEC50:  4nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101545(US8530652, 72 | US8530652, 124 | US8530494, 107)
Affinity DataKi:  16nM EC50:  4.40nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101541(US8530652, 68 | US8530652, 120 | US8530494, 104)
Affinity DataKi:  6.70nM EC50:  20nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389108(CHEMBL2064632)
Affinity DataEC50:  7nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101504(US8530652, 31 | US8524699, 91 | US8524710, 82)
Affinity DataKi:  7.20nM EC50:  21nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389117(CHEMBL2064562)
Affinity DataEC50:  9nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389116(CHEMBL2064561)
Affinity DataEC50:  11nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101476(US8530652, 47 | US8530652, 3 | US8524710, 53)
Affinity DataKi:  11nM EC50:  16nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389111(CHEMBL2064555)
Affinity DataEC50:  12.6nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101475(US8530652, 2 | US8530652, 46 | US8524710, 52)
Affinity DataKi:  14nM EC50:  36nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389119(CHEMBL2064564)
Affinity DataEC50:  15nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101535(US8530652, 113 | US8530652, 62 | US8530494, 104)
Affinity DataKi:  15nM EC50:  15nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389122(CHEMBL2064629)
Affinity DataEC50:  16nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101515(US8530670, 31 | US8530652, 42 | US8524699, 26)
Affinity DataKi:  16nM EC50:  340nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101513(US8530652, 85 | US8530652, 40 | US8524699, 18)
Affinity DataKi:  18nM EC50:  98nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101524(US8530652, 96 | US8530652, 51)
Affinity DataKi:  18nM EC50:  31nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389110(CHEMBL2064630)
Affinity DataEC50:  18nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101534(US8530652, 112 | US8530652, 61 | US8530494, 202)
Affinity DataKi:  22nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101553(US8530652, 132 | US8530652, 80 | US8530494, 215)
Affinity DataKi:  120nM EC50:  20nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101504(US8530652, 31 | US8524699, 91 | US8524710, 82)
Affinity DataKi:  20nM EC50:  103nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101540(US8530652, 67 | US8530652, 118 | US8530494, 205)
Affinity DataKi:  280nM EC50:  20nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389115(CHEMBL2064560)
Affinity DataEC50:  21nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101507(US8530652, 79 | US8530652, 34 | US8524710, 86)
Affinity DataKi:  21nM EC50:  778nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101514(US8530652, 86 | US8530652, 41 | US8524699, 22)
Affinity DataKi:  24nM EC50:  147nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101518(US8530652, 45 | US8530652, 90 | US8524699, 46)
Affinity DataKi:  25nM EC50:  32nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389120(CHEMBL2064565)
Affinity DataEC50:  28nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389113(CHEMBL2064558)
Affinity DataEC50:  32nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101639(US8530652, 84)
Affinity DataKi:  34nM EC50:  455nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389118(CHEMBL2064563)
Affinity DataEC50:  36nMAssay Description:Inhibition of PAK4-mediated GEF-H1 phosphorylation at Ser810 by cell based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101485(US8530652, 56 | US8530652, 12 | US8524710, 62)
Affinity DataKi:  38nM EC50:  78nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101556(US8530652, 1)
Affinity DataKi:  41nM EC50: >2.00E+3nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101506(US8530652, 33 | US8530652, 78 | US8524710, 85)
Affinity DataKi:  47nM EC50:  618nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

TargetSerine/threonine-protein kinase PAK 4(Human)
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101638(US8530652, 83)
Affinity DataKi:  58nM EC50:  84nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2013
Entry Details
US Patent

Displayed 1 to 50 (of 77 total ) | Next | Last >>
Jump to: